Detalhe da pesquisa
1.
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk.
Acta Pharmacol Sin
; 44(2): 446-453, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896694
2.
Alterations in the composition of the gut microbiota affect absorption of cholecalciferol in severe osteoporosis.
J Bone Miner Metab
; 40(3): 478-486, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103840
3.
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors.
Menopause
; 30(7): 774-780, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279508
4.
Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective study.
Arch Osteoporos
; 17(1): 14, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020038